Qualifying a medical device CRO requires more than comparing services, timelines and fees. The sponsor needs evidence that the CRO can perform the delegated activities under the applicable regulatory framework, protect data integrity and support effective oversight throughout the investigation.
This checklist explains what to verify, which documents to request, which questions to ask and which warning signs to investigate before appointing a CRO for a medical device clinical investigation.
The guide focuses on medical devices and ISO 14155:2026. IVD clinical performance studies require a separate assessment under the IVDR and the standards applicable to IVD studies. For an IVD programme, review our IVD CRO services.
Start With the Activities You Intend to Delegate
CRO qualification should be proportionate to the activities, countries, device risks and data responsibilities included in the proposed scope.
Before evaluating providers, define whether the CRO will be responsible for regulatory submissions, site feasibility, project management, monitoring, safety reporting, data management, biostatistics, medical writing, vendor coordination or the complete clinical investigation.
The qualification assessment should then test the CRO’s ability to perform those specific activities. A broad corporate presentation or an ISO certificate does not replace activity-level evidence.
Qualifying Your Medical Device CRO Partner: A Strategic Evaluation Framework
Choosing the right Clinical Research Organization (CRO) is pivotal for medical device manufacturers seeking to navigate the intricacies of clinical investigations, regulatory compliance, and market success. The process of qualifying a Medical Device CRO goes beyond simple service comparisons; it requires a strategic evaluation framework that ensures the selected partner is not only capable but also highly aligned with the company’s specific needs and goals. This framework should consider a variety of critical factors, including expertise in clinical operations, regulatory acumen, quality assurance capabilities, and a proven track record of success in the medical device field. By adopting a holistic and rigorous approach to evaluating potential CRO partners, companies can foster successful collaborations that are essential for achieving their project milestones and long-term objectives.
Medical Device CRO Qualification Checklist
1. Relevant Medical Device Experience
Ask for examples of investigations involving a comparable device class, intended purpose, therapeutic area, clinical setting and regulatory pathway. The objective is to determine whether the proposed team understands the risks and evidence requirements of your project, rather than whether the CRO has worked with any medical device.
Evidence to request: anonymised project summaries, device classes, countries, study phases, regulatory pathways, services performed and the roles of the proposed team members.
Warning sign: experience is described only through broad terms such as MedTech, healthcare or clinical trials, without identifying comparable device investigations.
2. Regulatory Pathway Experience
The CRO should be able to explain how the proposed investigation fits within the relevant regulatory framework. For an EU study, this may include MDR Articles 62, 74 or 82, national requirements and the applicable competent authority and ethics committee procedures. For a US study, the assessment should cover the applicable IDE and IRB pathway.
Evidence to request: recent submission experience, examples of authority questions addressed, country-specific submission plans and a proposed responsibility matrix.
Warning sign: the regulatory strategy is presented as globally standardised without recognising national submission differences or the regulatory status of the device.
3. ISO 14155 Processes and Quality System
Do not assess ISO 14155 through a compliance statement alone. Review how the CRO applies the standard to the activities it will perform. ISO 14155:2026 covers the design, conduct, recording and reporting of medical device clinical investigations and defines responsibilities intended to protect subjects and ensure credible results.
Evidence to request: the applicable SOP index, training matrix, document control, deviations, CAPA, audit, monitoring, safety reporting, vendor oversight and change-control procedures. If the CRO claims certification to a standard, verify the certificate, issuing body, validity dates and scope.
Use our ISO 14155 CRO verification guide for a more detailed review of the evidence.
Warning sign: the CRO relies on a certificate or general GCP statement but cannot show how its procedures apply to medical device investigations.
4. Proposed Team and Governance
Qualification should cover the people who will perform the work, not only the company’s senior experts. Confirm the named project manager, clinical leads, monitors, data managers, statistician and medical writer, together with their availability and relevant experience.
Evidence to request: CVs, role descriptions, allocation assumptions, training records, backup arrangements, escalation routes and expected staff turnover controls.
Warning sign: senior experts participate in the sales process, but the delivery team is unnamed or will only be assigned after contract signature.
5. Site Feasibility and Monitoring
A site network is useful only when it is relevant to the target population, device, procedure and recruitment assumptions. Review how the CRO selects investigators, validates feasibility data and determines the monitoring model.
Evidence to request: feasibility methodology, investigator qualification criteria, recruitment assumptions, site activation process, monitoring approach, escalation thresholds and examples of monitoring documentation.
Warning sign: recruitment commitments are based on an unverified database or historical relationships rather than current site-level feasibility.
6. Data Management and Biostatistics
Confirm how the CRO will protect data integrity from database design through database lock and final analysis. The assessment should cover systems, validation, access controls, audit trails, data cleaning, coding, statistical planning, privacy and data transfers.
Evidence to request: data management plan template, statistical analysis plan template, system validation information, edit-check process, database-lock procedure, security controls and the list of subcontracted data services.
Warning sign: critical data or statistical activities are outsourced without a documented oversight and quality-control process.
7. Safety Reporting and Vendor Oversight
The CRO should demonstrate how serious adverse events, device deficiencies and other reportable information move from the site to the sponsor and competent authorities. Responsibilities, timelines and reconciliation procedures should be defined before the first subject is enrolled.
Evidence to request: safety management plan, reporting workflow, escalation process, reconciliation procedure, vendor qualification records and oversight arrangements for laboratories, imaging providers or other subcontractors.
Warning sign: the proposal states that safety reporting is included but does not define responsibilities, recipients, timelines or the systems used.
8. Commercial and Operational Fit
Compare proposals using the same scope, assumptions and acceptance criteria. A lower initial fee may exclude activities that later appear as change orders or remain with the sponsor.
Evidence to request: detailed scope, exclusions, deliverables, timeline assumptions, change-order rules, communication cadence, KPIs, audit rights, subcontractors, data ownership and study-transfer arrangements.
Warning sign: the proposal contains an attractive fixed price but does not define volumes, responsibilities, dependencies or the conditions that trigger additional fees.
A Four-Step CRO Qualification Process
- Define the Scope and Evaluation Criteria
List every activity that may be delegated and identify the critical requirements for the device, investigation, countries, data and regulatory pathway. Send the same scope and questions to every shortlisted CRO so that proposals remain comparable.
- Complete the Document Review
Review the proposed team, relevant project experience, SOP index, training records, quality-system evidence, system controls, vendor arrangements, insurance and the assumptions included in the proposal. Record missing or conditional evidence rather than accepting verbal confirmation.
- Conduct a Capability Assessment or Audit
Ask the CRO to walk through a realistic project scenario. Test how it would manage a protocol deviation, urgent safety event, recruitment issue, database change, underperforming site or subcontractor failure. Where the delegated activities are critical, conduct a remote or on-site qualification audit.
- Score the Evidence and Transfer Controls Into the Contract
Score each provider against predefined criteria and document the final decision. The contract, scope of work and responsibility matrix should then reflect the commitments made during qualification, including deliverables, oversight, escalation, audit rights, subcontractors, data ownership and exit arrangements.
Qualification does not end at contract signature. The sponsor should reassess the CRO when the scope changes, critical personnel or vendors change, serious quality issues arise or performance indicates that additional oversight is required.
Frequently Asked Questions About Medical Device CRO Qualification
Qualification depends on the activities being delegated. Relevant evidence can include comparable device experience, trained personnel, ISO 14155 processes, an appropriate quality system, regulatory submission experience, validated data systems, monitoring capability, safety-reporting procedures and documented oversight of subcontractors.
The review should cover the proposed team’s CVs, relevant project summaries, SOP index, training matrix, quality certificates where applicable, audit and CAPA processes, system validation, vendor list, insurance, data-security controls, proposal assumptions and the draft responsibility matrix.
ISO 13485 certification should not be treated as the only qualification criterion or assumed to be mandatory for every CRO activity. The sponsor should assess whether the CRO’s quality system is appropriate for the delegated work. If certification is claimed, verify the certificate’s scope, issuing body and validity, together with the procedures that apply to the investigation.
No. A CRO can perform delegated activities, but the sponsor must maintain appropriate oversight and ensure that the investigation complies with the applicable requirements. Responsibilities should be documented clearly in the contract, scope of work, communication plan and responsibility matrix.
A regulatory consultant primarily advises on strategy, classification, documentation or submissions. A CRO can also execute operational activities such as site management, monitoring, data management, biostatistics and study reporting. The correct model depends on which activities the sponsor needs to delegate. Neither arrangement removes the sponsor’s oversight responsibilities.
Compare proposals against the same scope, volumes, assumptions and acceptance criteria. Review what is included, excluded, subcontracted or dependent on the sponsor. The comparison should consider evidence quality, proposed personnel, oversight, timeline assumptions, change-order rules and total expected cost, not only the initial fee.
Evaluating a CRO for an Upcoming Medical Device Investigation?
Apply the same qualification criteria to MDx CRO. Ask us about the proposed team, relevant device experience, ISO 14155 processes, regulatory pathway, monitoring model, data controls, subcontractors and project governance.
Review our medical device CRO services or contact the clinical team to request a project-specific scope and capability discussion.
